The comprehensive investigation of transcription factor AP-2 alpha in lung adenocarcinoma

BACKGROUND: Transcription factor AP-2 alpha (TFAP2A) has been reported to participate in various tumors. However, the transcriptional levels and prognostic values of TFAP2A remain elusive in lung adenocarcinoma (LUAD). The purpose of the present study was to investigate the impact of the TFAP2A in L...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Hongli, Lin, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799082/
https://www.ncbi.nlm.nih.gov/pubmed/35117502
http://dx.doi.org/10.21037/tcr.2020.01.58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799082/
https://www.ncbi.nlm.nih.gov/pubmed/35117502
http://dx.doi.org/10.21037/tcr.2020.01.58

Ejemplares similares